Clover Health Investments... (CLOV)
| Bid | 4.45 |
| Market Cap | 2.25B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.19 |
| PE Ratio (ttm) | -23.61 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 4.5 |
| Volume | 6,190,824 |
| Avg. Volume (20D) | 5,340,276 |
| Open | 4.57 |
| Previous Close | 4.55 |
| Day's Range | 4.42 - 4.80 |
| 52-Week Range | 0.61 - 4.87 |
| Beta | undefined |
About CLOV
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee....
Analyst Forecast
According to 2 analyst ratings, the average rating for CLOV stock is "Buy." The 12-month stock price forecast is $5, which is an increase of 11.48% from the latest price.
Next Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago · seekingalpha.com
Clover Health: Undervalued Turnaround Play With Promising SaaS PotentialClover Health's revenue rose 8% in Q3 2024, driven by a 7% growth in Medicare Advantage premiums, despite exiting low-margin ACO REACH program. Cost control measures are paying off, with salaries and ...
